Cyrus J. Lawrence’s Edwards Lifesciences EW Stock Holding History

Cyrus J. Lawrence’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$86K	Hold	1,200	–	–	0.33%	39
2024 Q4	$88K	Hold	1,200	–	–	0.02%	89
2024 Q3	$79K	Hold	1,200	–	–	0.02%	92
2024 Q2	$110K	Hold	1,200	–	–	0.02%	79
2024 Q1	$114K	Buy	+1,200	New	+$101K	0.03%	83
2023 Q3	$83K	Hold	1,200	–	–	0.02%	83
2023 Q2	$113M	Hold	1,200	–	–	24.49%	1
2023 Q1	$99K	Hold	1,200	–	–	0.03%	82
2022 Q4	$90K	Hold	1,200	–	–	0.03%	89
2022 Q3	$99K	Hold	1,200	–	–	0.02%	84
2022 Q2	$114K	Hold	1,200	–	–	0.03%	97
2022 Q1	$141K	Buy	+1,200	New	+$135K	0.03%	95

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Cyrus J. Lawrence's EW Position: Q1 2025 in Review

Cyrus J. Lawrence held its Edwards Lifesciences (EW) position steady in Q1 2025 at 1,200 shares worth $86K. The position accounts for 0.33% of the portfolio, ranked #39.

Cyrus J. Lawrence first reported a position in EW in Q1 2022 and has held it in 12 quarters since. The position peaked at $113M in Q2 2023. 1,206 funds tracked by Wall St. Rank hold EW as of Q1 2025.

Cyrus J. Lawrence held 1,200 shares of Edwards Lifesciences worth $86K as of Q1 2025.
Cyrus J. Lawrence left its Edwards Lifesciences share count unchanged in Q1 2025.
Edwards Lifesciences made up 0.33% of Cyrus J. Lawrence's portfolio in Q1 2025, its #39 holding.
Cyrus J. Lawrence first reported a position in Edwards Lifesciences in Q1 2022 and has held it in 12 quarters since.
Cyrus J. Lawrence's Edwards Lifesciences position peaked at $113M in Q2 2023.
1,206 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on Cyrus J. Lawrence's 13F filing for Q1 2025, filed 15 May 2025.